Vnitr Lek 2012, 58(9):633-639

A comparison of two methods of long-term external ECG telemonitoring in patients after ablation for atrial fibrillation

J. Chovančík1, V. Bulková2, M. Fiala1,*, J. Gandalovičová2, Š. Královec2, R. Neuwirth1, H. Tolaszová2, O. Jiravský1, J. Brada2, J. Januška1
1 Oddělení kardiologie Nemocnice Podlesí a.s., Třinec, přednosta prim. MUDr. Marian Branny
2 MDT - Medical Data Transfer, s.r.o, Brno, vedoucí pracovník Mgr. Veronika Bulková, Ph.D.

Aim:
The aim of the study was to compare two methods of long-term ECG monitoring after atrial fibrillation (AF) ablation.

Methods:
The study included 279 patients with paroxysmal (n = 163) or persistent (n = 116) AF, who were followed up for 1 year after the first catheter ablation for AF. All patients were provided with episodic ECG recorder for 1 year and instructed to send at least 2 random ECG recordings per day and whenever they sensed symptoms. They were also provided with external loop recorder for 2-3 weeks at 6 and 12 months to enable more continuous ECG monitoring.

Results:
At the end of 39 ± 12 (12-60) month follow-up, 143 (88%) patients with paroxysmal AF, and 105 (91%) patients with persistent AF, respectively, remained in stable sinus rhythm. The efficacy of episodic recorder expressed as a ratio of patients with identified AF/atrial tachycardia (AT) out of all patients with a documented episode of AF/AT was superior to the efficacy of loop recorder. No AF/AT episode was recorded with the loop recorder that was not also documented by the episodic recorder. Of the patients with the AF/AT recurrence detected by the episodic recorder, the arrhythmia was also revealed by the loop recorder in 70% of the patients after paroxysmal AF ablation (p < 0.001), and in 52% of the patients after persistent AF ablation (p = 0.006). Asymptomatic AF/AT was present in 42 (26%) of patients with paroxysmal AF, and in 28 (24%) patients with persistent AF (p = 0.810). From conventional follow-up unexpected and clinically significant episode of AF/AT that required change in therapy was detected in 9 (5.5%) patients after ablation for paroxysmal AF, and in 4 (3.4%) patients after ablation for persistent FS.

Conclusion:
More episodes of AF/AT after ablation were detected by 1-year daily ECG monitoring using episodic recorder as compared to periodic ECG monitoring with loop recorder. Identification of clinically significant episodes of AF/AT unrecognized from conventional follow-up was low.

Keywords: atrial fibrillation; catheter ablation; ECG monitoring

Received: March 27, 2012; Accepted: April 19, 2012; Published: September 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chovančík J, Bulková V, Fiala M, Gandalovičová J, Královec Š, Neuwirth R, et al.. A comparison of two methods of long-term external ECG telemonitoring in patients after ablation for atrial fibrillation. Vnitr Lek. 2012;58(9):633-639.
Download citation

References

  1. Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640. Go to original source... Go to PubMed...
  2. Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atril fibrillation: the APAF study. J Am Coll Cardiol 2006; 48: 2340-2347. Go to original source... Go to PubMed...
  3. Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective multi-centre, randomized, controlled study (Catheter Ablation For The Cure of Atrial Fibrillation Study). Eur Heart J 2006; 27: 216-221. Go to original source... Go to PubMed...
  4. Jaïs P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-2505. Go to original source... Go to PubMed...
  5. Bulková V, Fiala M, Haman L et al. Zlepšení kvality života po ablaci dlouhodobě perzistentní versus paroxysmální fibrilace síní: výsledky dvouletého sledování. Vnitř Lék 2011; 57: 456-462. Go to PubMed...
  6. Hsu LF, Jaïs P, Sanders P et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383. Go to original source... Go to PubMed...
  7. Gentlesk PJ, Sauer WH, Gerstenfeld EP et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007; 18: 9-14. Go to original source... Go to PubMed...
  8. Oral H, Chugh A, Özaydin M et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765. Go to original source... Go to PubMed...
  9. Nademanee K, Schwab MC, Kosar EM et al. Clinical outcomes of catheter ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008; 51: 843-849. Go to original source... Go to PubMed...
  10. Themistoclakis S, Corrado A, Marchlinski FE et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010; 55: 735-743. Go to original source... Go to PubMed...
  11. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313. Go to original source... Go to PubMed...
  12. Piorkowski C, Kottkamp H, Tanner H et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16: 1286-1292. Go to original source... Go to PubMed...
  13. Senatore G, Stabile G, Bertaglia E et al. Role of transtelephonic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 2005; 45: 873-876. Go to original source... Go to PubMed...
  14. Neumann T, Ergodan A, Dill T et al. Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation. Europace 2006; 8: 495-498. Go to original source... Go to PubMed...
  15. Edgerton JR, Mahoney C, Mack MJ et al. Long-term monitoring after surgical ablation for atrial fibrillation: how much is enough? J Thorac Cardiovasc Surg 2011; 142: 162-165. Go to original source... Go to PubMed...
  16. Oral H, Veerareddy S, Good E et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004; 15: 920-924. Go to original source... Go to PubMed...
  17. Verma A, Minor S, Kilicaslan F et al. Incidence of atrial arrhythmias detected by permanent pacemakers (PPM) post-pulmonary vein antrum isolation (PVAI) for atrial fibrillation (AF): correlation with symptomatic recurrence. J Cardiovasc Electrophysiol 2007; 18: 601-606. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.